204 Brain Metastases 2.0: Expert Management Strategies and Challenging Cases

Tuesday, April 28
7:00 am - 9:00 am
Location: 151B; BCEC

Fee: $150
Advanced Practice Provider Fee: $150
Candidate and Medical Student Fee: $65

Moderator(s): Steven N. Kalkanis, MD, FAANS

Panelist(s): Andrew J. Fabiano, MD, FAANS; Jeffrey J. Olson, MD, FAANS; Claudio G. Yampolsky, MD, IFAANS (Argentina)

Brain metastases (BM) are commonly treated as a part of a general neurosurgical practice. Major changes in the management of brain metastases have occurred in the past decade. This course covers the management of brain metastases including:

  1. Stereotactic Radiosurgery (SR);
  2. Post-SR Metastases;
  3. Surgical Resection of BM from Eloquent Cortex;
  4. Targeted Therapy;
  5. Interactive Case Presentations to interactively discuss different management strategies.

Learning Objectives: After completing this educational activity, participants should be able to:

  • Describe advanced management strategies for brain metastases including resection from eloquent cortex, stereotactic radiosurgery, and immune therapy.
  • Describe complex stereotactic radiosurgical planning for large metastases, brainstem metastases, and cavities before and after resection.
  • Diagnose and manage post-stereotactic radiosurgery brain metastases. Describe the advantages and shortcomings of neuroimaging techniques.
  • Develop an understanding of the role LITT and bevacizumab has in the treatment of post-SR brain metastases.
  • Describe the current literature on the role of immune therapy as a primary treatment for brain metastases. Discuss current treatment algorithms for BM of various primary tumor types that incorporate immune therapies.